Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
60,623,914
-
Share change
-
-15,083
-
Total reported value
-
$136,403,522
-
Put/Call ratio
-
36%
-
Price per share
-
$2.25
-
Number of holders
-
133
-
Value change
-
+$58,570
-
Number of buys
-
67
-
Number of sells
-
58
Institutional Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q2 2024
As of 30 Jun 2024,
Xeris Biopharma Holdings, Inc. - COM (XERS) was held by
133 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,623,914 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, CAXTON CORP, MPM BIOIMPACT LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Rosalind Advisors, Inc., MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, and CenterBook Partners LP.
This page lists
132
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.